早幼粒细胞白血病蛋白

维基百科,自由的百科全书
跳转至: 导航搜索
Promyelocytic leukemia
早幼粒细胞白血病蛋白
PDB rendering based on 1bor.
有效结构
PDB 直系同源检索:PDBe, RCSB
标识
代号 PML; MYL; PP8675; RNF71; TRIM19
扩展标识 遗传学102578 鼠基因104662 同源基因13245 GeneCards: PML Gene
直系同源体
物种 人类 小鼠
Entrez 5371 18854
Ensembl ENSG00000140464 ENSMUSG00000036986
UniProt P29590 Q60953
mRNA序列 NM_002675 NM_008884
蛋白序列 NP_002666 NP_032910
基因位置 Chr 15:
74.29 – 74.34 Mb
Chr 9:
58.22 – 58.25 Mb
PubMed查询 [1] [2]

早幼粒细胞白血病蛋白是指可能的转录因子可能的转录因子(英语:Probable transcription factor PML),是一个由人类基因 PML 编码的抑癌蛋白。

功能[编辑]

互作[编辑]

早幼粒细胞白血病蛋白可与下列蛋白質发生交互作用

参见[编辑]

参考文献[编辑]

  1. ^ Kojic, S; Medeot, E; Guccione, E; Krmac, H; Zara, I; Martinelli, V; 等. The Ankrd2 protein, a link between the sarcomere and the nucleus in skeletal muscle. J. Mol. Biol. May 2004, 339 (2): 313–25. PMID 15136035. doi:10.1016/j.jmb.2004.03.071.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  2. ^ 2.0 2.1 Zhong, S; Delva, L; Rachez, C; Cenciarelli, C; Gandini, D; Zhang, H; 等. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins. Nat. Genet. Nov 1999, 23 (3): 287–95. PMID 10610177. doi:10.1038/15463.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  3. ^ 3.0 3.1 Matsuzaki, K; Minami, T; Tojo, M; Honda, Y; Saitoh, N; Nagahiro, S; 等. PML-nuclear bodies are involved in cellular serum response. Genes Cells. Mar 2003, 8 (3): 275–86. PMID 12622724.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  4. ^ Doucas, V; Tini, M; Egan, DA; Evans, RM. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc. Natl. Acad. Sci. U.S.A. Mar 1999, 96 (6): 2627–32. PMC 15819. PMID 10077561.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  5. ^ Marcello, A; Ferrari, A; Pellegrini, V; Pegoraro, G; Lusic, M; Beltram, F; 等. Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein. EMBO J. May 2003, 22 (9): 2156–66. PMC 156077. PMID 12727882. doi:10.1093/emboj/cdg205.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  6. ^ Ishov, AM; Sotnikov, AG; Negorev, D; Vladimirova, OV; Neff, N; Kamitani, T; 等. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. Oct 1999, 147 (2): 221–34. PMC 2174231. PMID 10525530.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  7. ^ Li, H; Leo, C; Zhu, J; Wu, X; O'Neil, J; Park, EJ; 等. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol. Cell. Biol. Mar 2000, 20 (5): 1784–96. PMC 85360. PMID 10669754.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  8. ^ Lehembre, F; Müller, S; Pandolfi, PP; Dejean, A. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML. Oncogene. Jan 2001, 20 (1): 1–9. PMID 11244500. doi:10.1038/sj.onc.1204063.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  9. ^ Zhong, S; Salomoni, P; Ronchetti, S; Guo, A; Ruggero, D; Pandolfi, PP. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis. J. Exp. Med. Feb 2000, 191 (4): 631–40. PMC 2195846. PMID 10684855.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  10. ^ Tsuzuki, S; Towatari, M; Saito, H; Enver, T. Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17)-generated PML-retinoic acid receptor alpha oncoprotein. Mol. Cell. Biol. Sep 2000, 20 (17): 6276–86. PMC 86102. PMID 10938104.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  11. ^ 11.0 11.1 11.2 11.3 11.4 Khan, MM; Nomura, T; Kim, H; Kaul, SC; Wadhwa, R; Shinagawa, T; 等. Role of PML and PML-RARalpha in Mad-mediated transcriptional repression. Mol. Cell. Jun 2001, 7 (6): 1233–43. PMID 11430826.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  12. ^ 12.0 12.1 Wu, WS; Vallian, S; Seto, E; Yang, WM; Edmondson, D; Roth, S; 等. The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases. Mol. Cell. Biol. Apr 2001, 21 (7): 2259–68. PMC 86860. PMID 11259576. doi:10.1128/MCB.21.7.2259-2268.2001.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  13. ^ Topcu, Z; Mack, DL; Hromas, RA; Borden, KL. The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth control. Oncogene. Nov 1999, 18 (50): 7091–100. PMID 10597310. doi:10.1038/sj.onc.1203201.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  14. ^ Shin, J; Park, B; Cho, S; Lee, S; Kim, Y; Lee, SO; 等. Promyelocytic leukemia is a direct inhibitor of SAPK2/p38 mitogen-activated protein kinase. J. Biol. Chem. Sep 2004, 279 (39): 40994–1003. PMID 15273249. doi:10.1074/jbc.M407369200.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  15. ^ Dahle, Ø; Bakke, O; Gabrielsen, OS. c-Myb associates with PML in nuclear bodies in hematopoietic cells. Exp. Cell Res. Jul 2004, 297 (1): 118–26. PMID 15194430. doi:10.1016/j.yexcr.2004.03.014.  已忽略未知参数|author-separator= (帮助); 已忽略未知参数|author-name-separator= (帮助)
  16. ^ 16.0 16.1 Kurki, S; Latonen, L; Laiho, M. Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization. J. Cell. Sci. Oct 2003, 116 (Pt 19): 3917–25. PMID 12915590. doi:10.1242/jcs.00714.  已忽略未知参数|author-separator= (帮助); 已忽略未知参数|author-name-separator= (帮助)
  17. ^ 17.0 17.1 Bernardi, R; Scaglioni, PP; Bergmann, S; Horn, HF; Vousden, KH; Pandolfi, PP. PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat. Cell Biol. Jul 2004, 6 (7): 665–72. PMID 15195100. doi:10.1038/ncb1147.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  18. ^ Zhu, H; Wu, L; Maki, CG. MDM2 and promyelocytic leukemia antagonize each other through their direct interaction with p53. J. Biol. Chem. Dec 2003, 278 (49): 49286–92. PMID 14507915. doi:10.1074/jbc.M308302200.  已忽略未知参数|author-separator= (帮助); 已忽略未知参数|author-name-separator= (帮助)
  19. ^ Wei, X; Yu, ZK; Ramalingam, A; Grossman, SR; Yu, JH; Bloch, DB; 等. Physical and functional interactions between PML and MDM2. J. Biol. Chem. Aug 2003, 278 (31): 29288–97. PMID 12759344. doi:10.1074/jbc.M212215200.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  20. ^ Wu, WS; Xu, ZX; Ran, R; Meng, F; Chang, KS. Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions. Oncogene. May 2002, 21 (24): 3925–33. PMID 12032831. doi:10.1038/sj.onc.1205491.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  21. ^ Hong, SH; Yang, Z; Privalsky, ML. Arsenic trioxide is a potent inhibitor of the interaction of SMRT corepressor with Its transcription factor partners, including the PML-retinoic acid receptor alpha oncoprotein found in human acute promyelocytic leukemia. Mol. Cell. Biol. Nov 2001, 21 (21): 7172–82. PMC 99892. PMID 11585900. doi:10.1128/MCB.21.21.7172-7182.2001.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  22. ^ Fogal, V; Gostissa, M; Sandy, P; Zacchi, P; Sternsdorf, T; Jensen, K; 等. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. Nov 2000, 19 (22): 6185–95. PMC 305840. PMID 11080164. doi:10.1093/emboj/19.22.6185.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  23. ^ Guo, A; Salomoni, P; Luo, J; Shih, A; Zhong, S; Gu, W; 等. The function of PML in p53-dependent apoptosis. Nat. Cell Biol. Oct 2000, 2 (10): 730–6. PMID 11025664. doi:10.1038/35036365.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  24. ^ Alcalay, M; Tomassoni, L; Colombo, E; Stoldt, S; Grignani, F; Fagioli, M; 等. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol. Cell. Biol. Feb 1998, 18 (2): 1084–93. PMC 108821. PMID 9448006.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  25. ^ Kawasaki, A; Matsumura, I; Kataoka, Y; Takigawa, E; Nakajima, K; Kanakura, Y. Opposing effects of PML and PML/RAR alpha on STAT3 activity. Blood. May 2003, 101 (9): 3668–73. PMID 12506013. doi:10.1182/blood-2002-08-2474.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  26. ^ Lin, DY; Shih, HM. Essential role of the 58-kDa microspherule protein in the modulation of Daxx-dependent transcriptional repression as revealed by nucleolar sequestration. J. Biol. Chem. Jul 2002, 277 (28): 25446–56. PMID 11948183. doi:10.1074/jbc.M200633200.  已忽略未知参数|author-separator= (帮助); 已忽略未知参数|author-name-separator= (帮助)
  27. ^ Kamitani, T; Nguyen, HP; Kito, K; Fukuda-Kamitani, T; Yeh, ET. Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J. Biol. Chem. Feb 1998, 273 (6): 3117–20. PMID 9452416.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  28. ^ Vallian, S; Chin, KV; Chang, KS. The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter. Mol. Cell. Biol. Dec 1998, 18 (12): 7147–56. PMC 109296. PMID 9819401.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  29. ^ Xu, ZX; Timanova-Atanasova, A; Zhao, RX; Chang, KS. PML colocalizes with and stabilizes the DNA damage response protein TopBP1. Mol. Cell. Biol. Jun 2003, 23 (12): 4247–56. PMC 156140. PMID 12773567.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  30. ^ Takahashi, H; Hatakeyama, S; Saitoh, H; Nakayama, KI. Noncovalent SUMO-1 binding activity of thymine DNA glycosylase (TDG) is required for its SUMO-1 modification and colocalization with the promyelocytic leukemia protein. J. Biol. Chem. Feb 2005, 280 (7): 5611–21. PMID 15569683. doi:10.1074/jbc.M408130200.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)
  31. ^ Koken, MH; Reid, A; Quignon, F; Chelbi-Alix, MK; Davies, JM; Kabarowski, JH; 等. Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc. Natl. Acad. Sci. U.S.A. Sep 1997, 94 (19): 10255–60. PMC 23349. PMID 9294197.  已忽略未知参数|author-name-separator= (帮助); 已忽略未知参数|author-separator= (帮助)

延伸阅读[编辑]

外部链接[编辑]